Logo image of TESB.BR

TESSENDERLO GROUP (TESB.BR) Stock Fundamental Analysis

Europe - EBR:TESB - BE0003555639 - Common Stock

25.675 EUR
+0.07 (+0.29%)
Last: 9/17/2025, 5:29:59 PM
Fundamental Rating

4

Overall TESB gets a fundamental rating of 4 out of 10. We evaluated TESB against 66 industry peers in the Chemicals industry. The financial health of TESB is average, but there are quite some concerns on its profitability. TESB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

TESB had negative earnings in the past year.
In the past year TESB had a positive cash flow from operations.
Each year in the past 5 years TESB has been profitable.
TESB had a positive operating cash flow in each of the past 5 years.
TESB.BR Yearly Net Income VS EBIT VS OCF VS FCFTESB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

TESB's Return On Assets of -0.96% is on the low side compared to the rest of the industry. TESB is outperformed by 62.12% of its industry peers.
With a Return On Equity value of -1.52%, TESB is not doing good in the industry: 60.61% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 2.47%, TESB is in line with its industry, outperforming 45.45% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for TESB is in line with the industry average of 6.62%.
Industry RankSector Rank
ROA -0.96%
ROE -1.52%
ROIC 2.47%
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
TESB.BR Yearly ROA, ROE, ROICTESB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

TESB's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 2.61%, TESB perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
TESB's Operating Margin has declined in the last couple of years.
TESB has a Gross Margin of 19.33%. This is in the lower half of the industry: TESB underperforms 72.73% of its industry peers.
TESB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.61%
PM (TTM) N/A
GM 19.33%
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
TESB.BR Yearly Profit, Operating, Gross MarginsTESB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

6

2. Health

2.1 Basic Checks

TESB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for TESB has been reduced compared to 1 year ago.
TESB has more shares outstanding than it did 5 years ago.
TESB has a worse debt/assets ratio than last year.
TESB.BR Yearly Shares OutstandingTESB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
TESB.BR Yearly Total Debt VS Total AssetsTESB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.06 indicates that TESB is not a great score, but indicates only limited risk for bankruptcy at the moment.
TESB has a Altman-Z score of 2.06. This is comparable to the rest of the industry: TESB outperforms 43.94% of its industry peers.
TESB has a debt to FCF ratio of 2.34. This is a good value and a sign of high solvency as TESB would need 2.34 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.34, TESB belongs to the top of the industry, outperforming 95.45% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that TESB is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.06, TESB belongs to the best of the industry, outperforming 89.39% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 2.34
Altman-Z 2.06
ROIC/WACC0.35
WACC7.15%
TESB.BR Yearly LT Debt VS Equity VS FCFTESB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

TESB has a Current Ratio of 1.94. This is a normal value and indicates that TESB is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of TESB (1.94) is better than 60.61% of its industry peers.
TESB has a Quick Ratio of 1.18. This is a normal value and indicates that TESB is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of TESB (1.18) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.18
TESB.BR Yearly Current Assets VS Current LiabilitesTESB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The earnings per share for TESB have decreased strongly by -131.08% in the last year.
Measured over the past years, TESB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.75% on average per year.
The Revenue has been growing slightly by 2.05% in the past year.
Measured over the past years, TESB shows a quite strong growth in Revenue. The Revenue has been growing by 8.72% on average per year.
EPS 1Y (TTM)-131.08%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-116.23%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%7.08%

3.2 Future

Based on estimates for the next years, TESB will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.92% on average per year.
Based on estimates for the next years, TESB will show a small growth in Revenue. The Revenue will grow by 3.83% on average per year.
EPS Next Y3.33%
EPS Next 2Y20.55%
EPS Next 3Y19.92%
EPS Next 5YN/A
Revenue Next Year2.34%
Revenue Next 2Y3.91%
Revenue Next 3Y3.83%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TESB.BR Yearly Revenue VS EstimatesTESB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
TESB.BR Yearly EPS VS EstimatesTESB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TESB. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 15.40 indicates a correct valuation of TESB.
TESB's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TESB is cheaper than 68.18% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, TESB is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 15.4
TESB.BR Price Earnings VS Forward Price EarningsTESB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

90.91% of the companies in the same industry are more expensive than TESB, based on the Enterprise Value to EBITDA ratio.
TESB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. TESB is cheaper than 84.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.04
EV/EBITDA 5.06
TESB.BR Per share dataTESB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TESB does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as TESB's earnings are expected to grow with 19.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.55%
EPS Next 3Y19.92%

4

5. Dividend

5.1 Amount

TESB has a Yearly Dividend Yield of 2.02%.
TESB's Dividend Yield is comparable with the industry average which is at 3.04.
TESB's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.02%

5.2 History

On average, the dividend of TESB grows each year by 6.16%, which is quite nice.
Dividend Growth(5Y)6.16%
Div Incr Years0
Div Non Decr Years2
TESB.BR Yearly Dividends per shareTESB.BR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

The earnings of TESB are negative and hence is the payout ratio. TESB will probably not be able to sustain this dividend level.
The dividend of TESB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-166.05%
EPS Next 2Y20.55%
EPS Next 3Y19.92%
TESB.BR Yearly Income VS Free CF VS DividendTESB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

TESSENDERLO GROUP

EBR:TESB (9/17/2025, 5:29:59 PM)

25.675

+0.07 (+0.29%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-21 2025-08-21
Earnings (Next)N/A N/A
Inst Owners5.92%
Inst Owner ChangeN/A
Ins Owners67.43%
Ins Owner ChangeN/A
Market Cap1.54B
Analysts74
Price Target27.8 (8.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.02%
Yearly Dividend0.88
Dividend Growth(5Y)6.16%
DP-166.05%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.93%
PT rev (3m)0.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-25.96%
EPS NY rev (3m)-25.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.05%
Revenue NY rev (3m)-2.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.4
P/S 0.56
P/FCF 14.04
P/OCF 5.35
P/B 0.87
P/tB 1
EV/EBITDA 5.06
EPS(TTM)-0.45
EYN/A
EPS(NY)1.67
Fwd EY6.5%
FCF(TTM)1.83
FCFY7.12%
OCF(TTM)4.8
OCFY18.68%
SpS45.64
BVpS29.62
TBVpS25.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.96%
ROE -1.52%
ROCE 3.29%
ROIC 2.47%
ROICexc 2.77%
ROICexgc 3.14%
OM 2.61%
PM (TTM) N/A
GM 19.33%
FCFM 4.01%
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
ROICexc(3y)6.83%
ROICexc(5y)8.71%
ROICexgc(3y)7.61%
ROICexgc(5y)9.79%
ROCE(3y)8.33%
ROCE(5y)10.06%
ROICexcg growth 3Y-43.17%
ROICexcg growth 5Y-19.86%
ROICexc growth 3Y-44.09%
ROICexc growth 5Y-20.16%
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
F-Score6
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 2.34
Debt/EBITDA 0.38
Cap/Depr 80.05%
Cap/Sales 6.5%
Interest Coverage 7.18
Cash Conversion 97.86%
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.18
Altman-Z 2.06
F-Score6
WACC7.15%
ROIC/WACC0.35
Cap/Depr(3y)86.45%
Cap/Depr(5y)81.94%
Cap/Sales(3y)5.77%
Cap/Sales(5y)5.54%
Profit Quality(3y)143.93%
Profit Quality(5y)139.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-131.08%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-116.23%
EPS Next Y3.33%
EPS Next 2Y20.55%
EPS Next 3Y19.92%
EPS Next 5YN/A
Revenue 1Y (TTM)2.05%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%7.08%
Revenue Next Year2.34%
Revenue Next 2Y3.91%
Revenue Next 3Y3.83%
Revenue Next 5YN/A
EBIT growth 1Y10.97%
EBIT growth 3Y-34.22%
EBIT growth 5Y-13.98%
EBIT Next Year266.59%
EBIT Next 3Y56.25%
EBIT Next 5YN/A
FCF growth 1Y88.36%
FCF growth 3Y0.11%
FCF growth 5Y5.75%
OCF growth 1Y37.17%
OCF growth 3Y10.33%
OCF growth 5Y8.69%